Blog / Archives
Biotech Bull Market Rolls On in a Volatile Q2 2015: XBI Up 12.4%
Dealmaking and Fast Money Fuel Biotechs Q2 2015 Review Despite a major down trend at the end of April and the recent sell-off, the sector outperformed in Q2 of 2015. The S&P was down 1% and flat...
Biotech Stocks Lose Momentum with Greece Crisis; Blockbuster Immunotherapy Deal
Biotech Stocks in Broad Sell-Off The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down...
Notes from BIO 2015 #2 Recap and Biotechnology Trends-Gene Therapy, AMR
Edited 6/27 BIO 2015 #2 Gene Therapy and Antimicrobial Resistance (AMR) 6/26 This is a continuation of our previous update for BIO 2015 #1. Keep in mind these are notes not complete articles. Next...
Notes from BIO 2015 #1 Recap and Biotechnology Trends-M&A, Precision Medicine
Updated 6/25 Precision Medicine -Novel Prevention and Treatment Strategies Lead The Way A New Initiative on Precision Medicine — NEJM Over 15,000 attended BIO 2015 in Philadelphia including 1100...
Biotech Stocks Hit New Highs-Large Caps Lead The Way…Update-2 June 25
Update -2 ... June 25... IBB off all time high of 379.97 SCOTUS opinion in favor of ACA (ObamaCare) is favorable to hospital stocks and positive for HC sector overall as we have assumed since 2010....
BIO 2015 in Philadelphia next week-June 15-18
We will be attending the BIO International Convention in Philadelphia next week. Sign up now to receive life science industry news.
Slower Growth in Diagnostics Stocks Except for NexGen Sequencing and Molecular
New technologies in diagnostics and tools are driving growth: NexGen sequencing, molecular and "point-of-care" testing platforms and veterinary testing. M&A and consolidation should continue....
Biotech ETF Trending Shows Shift To Speculative Stocks: XBI
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well. Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc Rapid Fire...
ASCO Rally Fades But Spec Stocks Rock: FCSC,RXDX
ASCO Week in Review- Rayno Biopharmaceutical Stocks The market action over the past week focused on speculative stocks rather than the overall biopharmaceutical sector. Major ETFs over five days...
ASCO 2015 Biotech Movers Day Two: FCSC, JUNO, RXDX
Update-1 BLUE Drops 1.96% and 1.77% After Hours 6/3 In the bubbly CAR-T world bluebird bio (BLUE) and Celgene announced a deal for for development of product candidates for B-cell maturation...